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Hypertrophy and Hyperplasia of Alveolar
Type 11 Cells in Response to Silica and
Other Pulmonary Toxicants
by Bruce E. Miller* and Gary E. R. Hook*
AlveolarTypeIIcellsservetwomajorfunctionsinthelung,bothofwhichareessentialforthepreser-
vation ofnormal lungfunction. First, Type Hcells synthesize and secrete pulmonary surfactant, and
second, theyfunctionasprogenitorcellsformaintainingthealveolarepithelium. TheTypeIIcellpopula-
tion ofthe lung is quite sensitive to the deposition oftoxicants in the distal lung, responding in two
principal ways. Damage to the Type I epithelium stimulates Type II ceils to proliferate and subse-
quently differentiate to replace the ixjured Type I ceils. Second, aportion ofthe Type II cell popula-
tionmaybecomehypertrophic. Bothofthese eventsarefrequent findings inthe diseased ordamaged
lung. The Type II cell changes are often associated with increases in surfactant pools. In those cases
where ultrastructural characteristicsofhypertrophic lypeIIcellswereexamined, theappearanceof
theseceilswasconsistentwiththatofanactivatedcelltype.Alterationsinthelamellarbodycompart-
mentareacommonfindinginhypertrophic lypeIIceils, withincreasesinbothlamellarbodysizeand
number. It is likely that the hypertrophic, or activated, Type II cells account for the increased levels
of surfactant found in the lungs after exposure to a variety of toxic agents. We examined, in detail,
Type II cellhyperplasia andhypertrophy inducedby silicadeposition. BothType II cellhyperplasia
and hypertrophy were prominent responses. The proliferative response led to an approximate
doubling of thenumberofTypeUcellsinthelung. ThehypertrophicresponseoftheTypeU cellpopula-
tion was aresult ofactivation ofbiosynthetic pathways for surfactant-associated phospholipids and
protein. The significance of this activation and the underlying mechanisms responsible for it are
unknown, butinviewoftherelativelygeneralizednature ofthehypertrophic response,theactivation
could be an important component in the lung's response to toxic insult.
Introduction
Twomajorfunctionsofalveolar Type II cellshavebeen
defined. First, alveolar TIype II cells synthesize and
secrete pulmonary surfactant, a function that is well
documented (1). Few would doubt the fundamental
importanceofthe Iype II cellinmaintainingthepatency
of the alveoli and distal airways. Second, Type II cells
serve as stem cells for the replacement of 'ype II cells
that are damaged as a consequence of pulmonary
disease or chemical-induced injury (2). In addition,
autoradiographic evidenceindicatesthatthe Iype II cell
is the progenitor cell for the Type I epithelium in the
developing lung (3).
AlthoughTypeIIcellfunctionisoffundamentalimpor-
tance to the well-being of the organism, very little is
known about the pathobiology ofthe Type II cell. Very
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few studies have examined Lype II cell function under
conditions of naturally occurring or chemically in-
duced lung disease. Perturbations of the surfactant
systemaccompanyanumberofhumanrespiratorycon-
ditions, including the neonatal and adult respiratory
distresssyndromes(4,5), idiopathicpulmonaryfibrosis
(6), and alveolarproteinosis(7,8), butthe causesofthe
surfactant abnormalities and their relationship to the
progression ofdiseasehave notbeen delineated. Inad-
dition, inexperimentalanimals, alterationsinsurfactant
levelshavebeenreportedfollowingexposureofthelung
toavarietyofchemicalandphysicalagents, suggesting
thatType IIcellsand thesurfactantsystem maybe im-
portantcomponentsintheresponseofthelungtoirnury.
Ourlaboratoryisinterestedinthemechanismsthrough
whichtoxicagentsinfluencethepulmonarysurfactant
system. Ofthe many agents reported to affect the sur-
factant system, perhaps the most potent is silica. The
increases in surfactant that occur in response to silica
depositioninthelunghavebeenwelldocumented(9-12),
and recently we have extended those studies to the
cellularlevel in an attempt to understand the underly-
ing mechanisms through which silica is acting.MILLERAND HOOK
In this review we will discuss our recent findings
concerning the effects of pulmonary toxicants on the
Type II cell population. Our major focus will be the
changes in Type II cells caused by silica and how those
changes may account for the increased levels of sur-
factantphospholipidsfoundinthelungsofsilica-exposed
rats. However, we emphasize that, while the response
ofthesurfactantsystemtosilicahasbeenthemostwell-
studied example of surfactant changes in chemical-
inducedlunginjury, itisprobablethatmanyothercom-
pounds could act through similar mechanisms.
The Type 11 Cell
Thealveolarepitheliumofthelung(Fig. 1)iscomposed
primarilyoftwocelltypes,TypeIandTypeIIcells.Type
Icellsaccountforapproximately 97% ofthesurfacearea
ofthealveolarepithelium(13). Thesesquamouscellspro-
vide a large surface area, allowing for the efficient ex-
change of gases between the alveolar space and the
vascular compartment. Type II cells are cuboidal cells,
andalthoughtheyoccupyonlyabout3% ofthealveolar
surface in the rat lung, they constitute approximately
63% ofthe total alveolarepithelial cells(13,14). Type II
cellsaretypicallyfoundincorners ornichesofalveolar
septa and are characterized by surface microvilli and
abundant mitochondria and rough endoplasmic
reticulum. The most distinctive ultrastructural feature
ofthe Type II cell is the cytoplasmic lamellar inclusion
body, the intracellular storage site of pulmonary sur-
factant (Fig. 1).
FI,URE 1. Alveolar septa in anormal rat lung. AL, Alveolar lumen-
CA, Capillary; IN, interstitial cell; Ti, Type I cell; T2, Type II cell;
lb, lamellar body adapted from Miller et al. (41).
Type II cells, in addition to producingsurfactant and
serving as a stem cell population for the maintenance
ofthealveolarepithelium, haveseveralotherfunctions-
allofwhichareessentialforlunghomeostasis. Thesein-
clude metabolism of foreign compounds and transepi-
thelial water movement. These Type II cell functions
havebeendiscussedindetailinarecentreview(15)and
will not be discussed here.
Type 11 Cell Hyperplasia
Damage tothe alveolarregionofthe lungresults in a
characteristic cellular response, regardless of the
injurious agent. Type I cells, perhaps because of their
relatively large surface area [approximately 4500/m2,
(13)] and attenuated cytoplasm, are quite sensitive to
toxic agents. Among the first cellular changes to be
observedfollowingexposuretoapulmonarytoxicantis
damage to Type I cells. [Type I cells appear to be in-
capable ofdividing(16).] Subsequenttotheproliferative
burst, a sufficient number ofType II cells differentiate
to replace the damaged Type I cells and restore the in-
tegrityofthealveolarepithelium(17,18). Differentiation
of Type II cells into Type I cells takes approximately
2 days (19). This response is now generally recognized
as a common reparative tissue reaction to alveolar in-
jury(2)andappearstobeessentialforthenormaltissue
architecture being restored (20,21).
Evaluation of Type II cell hyperplasia typically has
beenbased on qualitative histological examinations by
lightmicroscopy. Forquantitative determination ofthe
TMypeIIcellproliferativeresponse, electronmicroscopic,
morphometricanalysishasbeentheusualapproach(22).
Thismethodologyhasbeenusedtoexaminethecellular
changes occurring in the lungparenchyma in response
to oxygen (14,23) and asbestos (24,25). However, elec-
tronmicroscopic morphometrictechniquesarelengthy,
tedious, and expensive; thus they are not suitable for
routine use.
Light microscopy has been used to study Type II cell
populationkinetics. Theusualapproachhasbeentolabel
proliferatingcellswith3H-thymidine, followedbydeter-
minationofthelabelingindex, i.e., theproportionofthe
total cells incorporating 3H-thymidine. For example,
Adamson and Bowden (26) used the labeling index to
determine that Type II cell proliferation was maximal
2 to 3 days after intratrachael instillation of silica into
thelungsofmice. These same authors(27)showedthat
exposuretoshortcrocidoliteasbestosfibers(meanlength
of 24 ,um), on the other hand, produced only a slight
degreeoflypeIIcellhyperplasia(28).Thelabelingindex
methodhasalsobeenusedtostudyTypeIIcellprolifera-
tioninlungirnuryinducedbyoxygen(29), cadmium(30),
butylatedhydroxytoluene(31), andnitrogendioxide(32).
Inallofthesestudies, itwasfoundthattheproliferative
burst of the Type II cell population occurred within
several days of the beginning of the exposure.
Althoughthelabelingindexapproachhasbeenuseful,
it suffers from twomajordisadvantages. First, the pro-
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cedure merely detects cells that have incorporated
3H-thymidine. Whether or not that incorporation
actuallyreflectsthe degree ofcellproliferation maybe
difficult to ascertain. Second, it does not provide a
measure ofthe actual increase in cel number. Such in-
formation is useful when one desires to examine how a P s!'
toxic agent can affect the cellular makeup of the lung * Z
parenchyma (14,23,24). This information could be : 0
important in understanding the cellular mechanisms,
responsible forthe chronic effects oftoxicagents, e.g.,
i':i w.<<
pulmonary fibrosis, alveolar proteinosis, etc. -.
Wehaverecentlydeveloped asimple lightmicroscopy- *1
basedmorphometricprocedure forType IIcellquantita-
tion(33). Thisprocedure takes advantage ofthe obser-
vation that, in the alveolar region of the lung, Type II
cells are the only cell type containing alkaline
phosphataseactivity(34,35). Thealkalinephosphatase
activityislimitedtotheluminalmembrane oftheType
IIcellandprovides aconvenient markerfortheType II
cell at the lightmicroscopic level. Thisstainingpattern
was confirmed by electron microscopic histochemistry
(33). Figures2and3 showthealveolarregionsofacon-
trol and a silica-treated rat lung stained for alkaline
phosphatase activity. With thistechnique, Type II cells * :
areeasilydiscerniblefromothercelltypes, andtheType a 4
II cellhyperplasia inducedbysilica isreadily apparent. 50 t (
KL X :: :-XU: -::;: ::::FIGURE 3. Alkaline phosphatase staining ofthe alveolar region of a
ML m ^ - ::: ; ; . ratlung 14daysafterexposureto 10mgofsilica. Thehyperplastic
response of the Type II cell population is easily discernible.
Type II cell hyperplasia can be quickly and easily
quantitatedusingthemorphometricprocedure describ-
edbyMilleretal.(33). Themorphometricprocedure re-
iquresthatoniyalkalnephosphatase
nuclear profiles be counted. Although polymor-
phonuclear leukocytes contain alkaline phosphatase
1t, ;f; .i 'activity, these cells are easily distinguished from Type
.F!
.... 0 0 0II cells by their characteristic, segmented nuclear
-- :- :; ;_morphology. In addition, the alkaline phosphatase ac-
tivity of polymorphonuclear leukocytes is distributed
throughout the cytoplasm ofthe cell, whereas staining
of Type II cells is confined to their luminal surfaces.
:Type II cells in the lungs of rats, humans, and guinea
pigs stain positively for alkaline phosphatase, but
those cells in the lungs of mice and hamsters do not
stain by our procedure (Miler and Hook, unpublished
data).
We have used the alkaline phosphatase procedure to
quantitate changes induced by silica in the Type II cell
FIGURE 2. Distribution of alkaline phosphatase staining in the population of the lungs of rats. Following a single
alveolar region ofa normal rat lung. Alkaline phosphatase reac- intratracheal injection of 10 mg silica, the lype II cell
tion product appears as a bright red precipitate. Sections were
counterstained withHarris' hematoxylin. Arrowsindicateluminal populatlon approxunately doubled over a 4-week time
staining ofType II cells. period (Fig. 4) (33).
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FIGURE 5 Alkaline phosphatase staining and autoradiography of a
a Type II cell inStU 3H1thymidine (2 tCi/gbody weight) wasgiven
7 14 28 90 min before sacrifice.
Days After Silica
FIGURE 4. Changes inFType II cell population as a function of timea
afterdosing with 10 mgsilica. Each point representsthe mean ±
SD from three orfouranimals. Asterisk (*)indicatessignificantly
differentfromcorrespondingcontrolvalue(p < 0.05). From Miller
et al. (33).
An additional advantage of the alkaline phosphate
identification ofType II cells is that the technique can
be coupled with 3H-thymidine and autoradiography
to identifyIType IIcellsthatmaybeactivelyengaged in
synthesizingDNA(Fig. 5). Autoradiography doesnotin-(
terferewiththestainingoftheTypeIIcells. Inaddition,
the procedure is also applicable to the study ofType II
cells under conditions of in vitro cultivation (Fig. 6).
When combined with3H-thymidine labeling and auto-
radiography, thistechnique shouldbeextremely useful J
for examining Type II cell population kinetics, espe-
cially under conditions involving lung damage and
disease.
Type II Cell Hypertrophy
Type II cellhypertrophy isanotherfrequentlyreported FIGURE 6. Alkaline phosphatase staining and autoradiography of response of the Type II cell population to lung irjury. TypeIIcellsinprimaryculture.Thecellswereincubatedwith3H-
Numerousinvestigatorshavedescribedthepresenceof thymidine for 24 hr.
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hypertrophic Type II cells following exposure to a
pulmonary toxicant. The significance of the hyper-
trophic response ofType IIcellsfollowinglung injuryis
notknown, andthenatureofthehypertrophicresponse
hasreceivedverylittleattention, atleastpartlybecause
of the difficulty in examining the response in a quan-
titative manner.
In many instances where Type II cell hypertrophy
has been observed, alterations in lamellar bodies have
also been reported. The most frequently reported
lamellar body alterations in hypertrophic Type II cells
areincreasesinlamellarbodynumberand/oranincrease
inlamellarbodysize. Forexample, Asoetal. (36)reported
thathypertrophic Type II cellsinthelungsofratsgiven
bleomycin contained increased numbers of lamellar
bodies. A similar finding was reported by Kumar et al.
(37) in mice. Recently, Balis et al. (38) reported that
hypertrophic Type II cells in the lungs of rats exposed
to 3 ppm of ozone contained increased numbers of
lamellar bodies. Hypertrophic Type II cells in the lungs
of asbestos-exposed rats were characterized by more
numerous and larger lamellar bodies than seen in
normal Type IIcells(24,25). Theintravenousadministra-
tion of Freund's adjuvant to rabbits resulted in Type II
cellsthatcontainedlargerandmore numerouslamellar
bodies (39). Likewise, the lungs of rats exposed to
cigarettesmokefor25dayscontainedhypertrophiclype
IIcells with increased numbers oflamellarbodies (40).
Inthesilica-exposed lung, theultrastructuralchanges
that occurred in the lamellar body compartment of
hypertrophic Type II cells were evaluated morpho-
metrically, and it was found that these cells contained
lamellar bodies that were, on the average, twice the
volume of those found in normal Type II cells (Fig. 7,
Thble 1)(41). Inaddition, hypertrophic TypeIIcellscon-
tainedapproximately40% morelamellarbodiespercell.
Inthe case ofsilica, the hypertrophic response appears
to be progressive in nature with the number of hyper-
trophic Type II cells increasing over time (42).
In many of the studies cited previously, Type II cell
hypertrophy occurred concomitant to alveolar injury.
Diffuse alveolar injury, however, is apparently not a
prerequisitefortheinductionoflypeIIcellhypertrophy.
Gottschall et al. (43) reported that the antibiotic
oxytetracycline resulted in hypertrophic Type II cells
containing larger and more numerous lamellar bodies.
This occurred in the absence of any evidence of
alveolar epithelialinjury. Theauthorssuggestedthatthe
TypeIIcellchangeswereindicativeofincreasedproduc-
tionofpulmonarysurfactant. Similarly, Fringesetal.(44)
recently reported that the hypolipidemic, peroxisome
proliferating agent clofibrate produced, inthe absence
oflype II cell proliferation, hypertrophic Type II cells
containing increased numbers of lamellar bodies.
In several instances (36,38), Type II cell hypertrophy
appearedtoprecedeTypeIIcellhyperplasia. Inthestudy
with bleomycin by Aso et al. (36), Type II cell hyper-
trophy was observed prior to any morphological signs
10Opm
FIGURE 7. Electron micrographs of isolated Type II cells. (a) Type
II cell isolated from control rat lungs; (b) hypertrophic Type II
cell isolated from a rat lung 14 days after treatment with 10 mg
silica. The cell profiles shown were chosen because they most
closely approximated the mean caliper diameter ofthe cell type
which they represent. From Miller and Hook (70).
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lkble 1. Morphometric analysis of control and hypertrophic
Type II cells.a
Type II cell population
Controlb Hypertrophicb
Cell volume, Mm 354 ± 18C 523 ± 29C
(311)d (261)d
Lamellar body 0.32 ± 0.07 0.66 ± 0.10c
volume, #3 (381) (409)
Lamellar bodies 96 ± 43 131 ± 84C
per Type II cell (41) (32)
aAdapted from Miller and Hook (41).
bValues are mean ofNdeterminations ± SD.
cSignificantly different from control (p < 0.05).
dNumber of individual profiles measures.
ofType Icellinjury. Thus, Type IIcellhypertrophy may
be a response separate from that which induces Type
II cellproliferation. Consistentwiththisreasoningisthe
observationthatinseveral cases TypeIIcellhypertrophy
has been shown to persist even in the absence of con-
tinuing Type I celldamage (24,37,41,42). The nature of
the alterations in lamellar bodies in hypertrophic Type
II cells suggest that these cells may have an increased
capacity for surfactant production.
Pulmonary Surfactant
Pulmonary surfactant is absolutely essential for
normallungfunction. Atend-expiration, whenalveolar
volume is minimal, surface tension forces would cause
collapse of alveoli if surfactant were not present. An
importantbiophysicalpropertyofsurfactantisthat upon
compression, as occurs at end-expiration, its surface
tension decreases to near zero. Thus, the presence of
surfactant maintains alveolar stability at low lung
volumes (45).
In the lung, surfactant is located in two distinct, but
interrelated, compartments. Extracellular surfactant
refers to surfactant that is present in the lumen ofthe
alveolianddistalairways. Thissurfactantcompartment
mayberemoved quantitativelyfromthelungsbyusing
bronchoalveolar lavage (46). With proper use of this
technique, upto95% oftheextracellularsurfactant can
be recovered (47). Intracellular surfactant refers to
the lamellar body compartment within Type II cells.
This compartment can be recovered by any of several
density gradient centrifugation procedures [for exam-
ple(10,48)]. Thedevelopmentofreliabletechniquesfor
the isolation of surfactant has allowed changes in the
surfactant compartments in response to pulmonary
toxicants to be evaluated.
Isolatedsurfactantconsistsofabout90% lipidand 10%
protein by weight (49). Phospholipids account for
greater than80% ofthelipid componentofsurfactant.
Thephospholipidcompositionofpulmonarysurfactant
fromtheratlungisshowninlkble2.Thehighpercentage
of phosphatidylcholine, and in particular, disaturated
phosphatidylchloline accounts for the surface tension
¶lble 2. Phospholipid composition ofpulmonary surfactant
isolated from normal rats by bronchoalveolar lavage.
Phospholipid Composition, % of total phospholipid
Lysophosphatidylcholine 0.5
Sphingomyelin 1.1
Phosphatidylcholine
Unsaturated 30.4
Disaturated 54.5
Phosphatidylinositol 3.7
Phosphatidylserine 1.1
Phosphatidylethanolamine 3.9
Phosphatidylglycerol 4.9
aFrom Dethloff et al. (10).
lowering ability ofsurfactant. In addition to its unique
phospholipid composition, surfactant also contains
several surfactant-specific proteins that are important
in surfactant function (50).
Avarietyofcompoundshavebeenshowntoaffectsur-
factantlevels inthelung. Increasesinsurfactant levels
are afrequent finding inthe lungs oftoxicant-exposed
animals. Inthebleomycin-exposed lung, 'Iype II hyper-
trophywasassociatedwithincreasesinextracellularsur-
factant phospholipids (36). Exposure to oxidant gases
also results in increases in surfactant-associated
phospholipids. Increases in both the extracellular and
intracellularpoolsofsurfactanthave beenfoundfollow-
ingexposuretooxygen(51,52), ozone(38), andnitrogen
dioxide (53). Inhalation of cadmium aerosol (54) and
diesel exhaust (32) also resulted in increased ex-
tracellular surfactant.
Mineral dusts appear to be especially potent in pro-
moting the accumulation of surfactant phospholipids.
Increases in extracellular surfactant in response to
asbestosdepositionhavebeenreportedinseveralstudies
(55-57). Crystalline silica(alpha-quartz) isperhaps the
mostpowerfulinducerofsurfactantphospholipids. The
effects ofsilica on surfactant phospholipids have been
particularly well studied. Fallon (58) was the first to
reportthatsilicacausesanincreaseinthephospholipid
contentofthelung, anobservationthatwasincorrectly
attributed to macrophage influx and disintegration.
Heppleston and his colleagues (59-61) showed that
the majority ofthe increases inphospholipids in silica-
exposed lungs resulted from large increases in
phosphatidylcholineanddisaturatedphosphatidylcho-
line, which they suspected arose from pulmonary sur-
factant. Theseworkersbelievedthatthesilica-induced
pulmonaryphospholipidosis wassimilartoalveolarpro-
teinosis, a disease ofthe human lung characterized by
the accumulation oflarge amount oflipid(7). Gabor et
al. (9) demonstrated that silica deposition in the lungs
resulted in up to a 12-fold increase inextracellular sur-
factantphospholipids. Dethloffetal. (10-12)examined
the effects of silica on surfactant-associated phospho-
lipidsindetail. Theseauthorsfoundthat, alongwithin-
creases in extracellular surfactant, silica had an even
moredramaticeffectontheintracellularpoolofsurfac-
20HYPERTROPHYAND HYPERPLASIA OFALVEOLAR TYPEII CELLS
¶Nble 3. Intra- and extracellular surfactant-associated
phospholipid composition in the lungs of control and
silica-exposed rats.
Composition, % of total phospholipid
Intracellular Extracellular
Phospholipid Control Silica Control Silica
Lysophosphatidylcholine 1.5 0.5 0.5 1.0
Sphingomyelin 3.8 1.3 1.1 1.7
Phosphatidylcholine
Unsaturated 29.5 32.8 30.4 35.2
Disaturated 51.8 49.4 54.5 49.2
Phosphatidylinositol 2.4 6.2 3.7 5.3
Phosphatidylserine 1.6 1.1 1.1 1.2
Phosphatidylethanolamine 5.0 4.2 3.9 3.1
Phosphatidylglycerol 4.5 4.5 4.9 3.4
aIntracellular surfactant is the lamellarbody compartment within
TypeIIcells. Extracellularsurfactant referstosurfactant recovered
by bronchoalveolar lavage. From Dethloff et al. (10).
tant. Greaterthan 120-foldincreasesintheintracellular
surfactant pool could be induced (10). Despite these
enormousincreases, thephospholipidcompositionofthe
surfactant wassimilartothatincontrollungs(Thble 3).
Approximately 85% ofthe increase inphospholipids in
the lung caused by silica was associated with the sur-
factantsystem, indicatingthatthesurfactant system is
a specific target of silica (10).
An interesting finding in several of the studies men-
tioned above is that extracellular surfactant levels can
remain elevated, even many weeks after exposure to
mineral dusts. For example, Gabor et al. (9) found that
extracellular surfactant levelsremained elevated up to
26 weeks following exposure. Similarly, Richards and
Curtis(62)foundthattheincreasesinextracellular sur-
factantproducedbysilicaremainedapproximatelyfive
times higher than in control animals for as long as 48
weeks afterexposure. Increasesinsurfactant following
inhalationofchrysotileasbestosremainedapproximate-
ly 2.5-fold above controllevels up to 50 weeks after ex-
posure(57). Asbestos and silicaare wellknown asetio-
logic agents in the development ofpulmonary fibrosis.
Itis, therefore, conceivablethattheincreasesinsurfac-
tant induced by these fibrogenic dusts are somehow
relatedtotheprogressionofthefibroticprocess(62). In
thisregard, itisnoteworthythatnonfibrogenicdustsdo
not elicit a surfactant response (9,62).
It is apparent from the preceding discussion that an
increase in surfactant levels is a common response
to lung insult. Itshouldalsobenoted, however, thatin-
creasedsurfactantlevelsarenotageneralized response
of the lungs to all toxic chemicals. Some compounds
appear to cause a decrease in extracellular surfactant
levels. For example, the volatile, organic compounds
trichloroethylene, carbon tetrachloride, and gasoline
all appeartocausedecreasesinextracellularsurfactant
(63,64).
Surfactant Biosynthesis in the
Injured Lung
Although surfactant metabolism in the toxicant-
exposedlunghasnotbeenwellstudied, anumberofin-
vestigators (65-67) have proposed that stimulation of
biosynthesis isthe underlyingcause accountingforthe
accumulationofsurfactant. Youngetal. (51)foundthat,
in the oxygen-exposed lung, production of surfactant-
associated disaturatedphosphatidylcholine wasincreas-
ed at least 4-fold. Richards and Lewis (67) found that
tissueslicesfromsilica-exposedlungsincorporatedmore
[methyll4C]choline intophosphatidylcholine thantissue
slices from the control lungs. Miller and Hook (66) ex-
tended thisfindingand demonstrated that tissue slices
from silica-exposed lungs had increased rates of incor-
poration of [methyll4C]choline and 3H-palmitate into
lamellarbodyphosphatidylcholineanddisaturatedphos-
phatidylcholine; thiswasassociatedwithanincreasein
theactivityofcholinephosphatecytidylyltransferase, a
keyenzymeoftheCDP-cholinepathwayforthedenovo
biosynthesis of phosphatidylcholine.
'Ib better understand how exposure to toxicants may
affect surfactant production, several investigators
studied phospholipid biosynthesis inType II cells, that
were isolated from the lungs of exposed animals.
Kikkawaetal.(68)foundthatTypeIIcellsisolatedfrom
thelungsofrabbitsexposed tobleomycinhada 1.6-fold
higher level ofphosphatidylcholine biosynthesis. Type
II cellsisolated from the lungs ofrabbits exposed to ox-
ygen incorporated radiolabeled choline into
phosphatidylcholineanddisaturatedphosphatidylcho-
line at agreaterrate thanType II cells from unexposed
rabbits (52).
Wrightetal.(69)reportedthattheactivitiesofseveral
enzymes involved in phospholipid biosynthesis were
elevated in Type II cells isolated from the lungs of rats
exposed to nitrogen dioxide. Type II cells isolated from
the lungs of silica-treated rats also have an increased
capacity for the production of surfactant-associated
phospholipids (70).
Milleretal.(41)alsoshowedthathypertrophicType II
cellscouldbeisolated fromthe lungs ofratsexposed to
silica by intratracheal instillation. Not all Type II cells
inthelungsofsilica-exposedratsbecamehypertrophic,
and the process of Type II cell hypertrophy was pro-
gressive(42). ThemethoddevelopedbyMilleretal. (41)
could separate hypertrophic from nonhypertrophic
Type II cells. Compared with nonhypertrophic Type II
cells, thehypertrophicType II cellsincorporatedradio-
labeledcholineandpalmitateintophosphatidylcholine
and disaturated phosphatidylcholine at a greater rate
(70).
Inthesilica-treatedlung, activationoftheCDP-choline
pathway for the biosynthesis of phosphatidylcholine
appears to be the mechanism accounting for the in-
creasedproductionofphosphatidylcholine anddisatur-
atedphosphatidylcholinebyhypertrophicType IIcells.
Increased activities ofthe twoterminal enzymesofthe
CDP-cholinepathway, cholinephosphatecytidylyltrans-
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ferase(EC2.7.7.15)andcholinephosphotransferase (EC
2.7.8.2), were found in the hypertrophic Type II cells
(Miller and Hook, unpublished observations). Further,
the increase in the activity of cholinephosphate cyti-
dylyltransferase was shown to result from an increase
intheactivityofthemembrane-boundandnotthesolu-
bleformoftheenzyme. Thephysiologicallyactiveform
oftheenzymeappearstobethemembrane-boundform
(71).
In addition to increased biosynthesis of surfactant-
associated phospholipids, the biosynthesis is themajor
surfactant-associated protein [Mr 26,000-36,000, SP-A
(72)] was increased approximately 7-fold in the hyper-
trophicTypeIIcells(MilerandHook, unpublishedobser-
vations). Thus, hypertrophic Type II cells represent a
population of Type II cells in which the activation of
biosynthesisofboththephospholipid andprotein com-
ponents of surfactant has occurred.
The Significance of Type 11 Cell
Hyperplasia and Hypertrophy
Inmostoftheexamplesofincreasedsurfactantlevels
discussed above, Type II cell hyperplasia alone cannot
seem to account for the increase. In the case of silica,
duringaperiod whenType II cell numbers inthe lungs
increased only 2-fold, intracellular pools of surfactant
phospholipids increased 20-fold (33,66). There seems
little doubt thatthe increased levels ofsurfactant seen
inthelungsofsilica-exposed ratsisduetothepresence
of hypertrophic T5ype II cells. Within the hypertrophic
TIypeIIcells, increasedlevelsofsurfactantphospholipids
appeartobebroughtaboutthroughactivationofbiosyn-
thetic pathways. In fact, the hypertrophic state of the
cellsmayarisefromenhancedbiosynthesisofsurfactant
phospholipids.
Animportant questionthat must stillbeaddressed is
whatdoestheTypeIIcellactivationandtheaccumula-
tionofsurfactantmeanintermsofpulmonaryfunction?
Doincreasedlevelsofsurfactantservetosomehowpro-
tect the lungs, as suggested by the results of several
studies (62,73)? The activation ofType II cells and the
significanceofthesurfactantincreasesisanareawhich
has received very little attention, but in view of the
apparent generalized nature of the hypertrophic
response, animportantphysiologicalfunctionofthesur-
factant system may yet await discovery.
We thank Gary J. Baker for providing Figure 6.
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